Tumor-targeted delivery of silibinin and IPI-549 synergistically inhibit breast cancer by remodeling the microenvironment
Min Jiang, Kaiyong He, Tong Qiu, Jiahui Sun, Qi Liu, Xueqiong Zhang, Hua Zheng
Topics & Concepts
SilibininTumor microenvironmentCancer researchBreast cancerAngiogenesisCancerImmune systemPharmacologyMedicineDrug deliveryChemistryImmunologyInternal medicineOrganic chemistryNanoplatforms for cancer theranosticsImmune cells in cancerPeptidase Inhibition and Analysis